MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155,553 | -35.2% | 120,584 | -33.6% | 0.00% | -20.0% |
| Q2 2023 | $239,876 | -20.6% | 181,724 | -57.5% | 0.01% | -16.7% |
| Q1 2023 | $302,131 | +387.3% | 427,403 | +669.7% | 0.01% | +200.0% |
| Q2 2022 | $62,000 | -32.6% | 55,532 | -32.8% | 0.00% | 0.0% |
| Q1 2022 | $92,000 | -30.3% | 82,583 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $132,000 | -37.7% | 82,583 | -5.5% | 0.00% | -50.0% |
| Q3 2021 | $212,000 | -47.8% | 87,420 | -31.7% | 0.01% | -53.8% |
| Q2 2021 | $406,000 | -18.6% | 128,048 | -13.5% | 0.01% | -31.6% |
| Q1 2021 | $499,000 | +9.0% | 148,048 | +15.6% | 0.02% | +11.8% |
| Q4 2020 | $458,000 | +30.9% | 128,048 | -4.2% | 0.02% | -19.0% |
| Q3 2020 | $350,000 | – | 133,634 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
| Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
| Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
| Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
| Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
| DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
| Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
| Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
| Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |